Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed: 20,548
Companies: 1,769
Drugs tracked: 4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources

Quick answer

18F-PMPBB3 (APN-1607) PET imaging

2 mg hydromorphone

24/7 EEG™ SubQ

25% Carbohydrate solution (CHO drinking)

2L PEG

30% Nitrous oxide

4D

5-gene classification model

99mTc-4BOH SPECT myocardial perfusion imaging

A continuous intravenous infusion of 0.5-0.6 mg/kg/h Rocuronium Bromide Intravenous Solution (50 Mg/5 mL) to keep the target neuromuscular blockade (PTC = 1-2).

A single dose of liposomal bupivacaine is administered at the conclusion of surgery without adjunctive analgesics, followed by a supplemental dose 72 hours postoperatively.

AIM-CHD Mobile Health Intervention

ANKASCIN 568-P Red yeast rice capsules

ART initiation at time of HIV diagnosis

Abciximab local infusion

Accelerated partial breast irradiation

Accurate Prediction Artificial Intelligence Models

Akkermansia Probiotics

Alcohol(oral) and placebo

Ambrisentan

Amino acid-derived lipids

Amoxicillin

Antibiotic selection based on the antibiotic susceptibility testing

Antioxidant

Frequently asked questions